We extend our heartfelt thanks to everyone who supported our vision for a world where HIV is no longer a threat to health or happiness. Together we have made a difference. With Gift Aid, your generous ...
Novel regimens must match the high efficacy and safety observed with currently approved HIV treatments and do so with administration that is ideally minimally painful and can be performed outside ...
The aim of this study was to assess the cost per unit change in efficacy (HIV RNA decreases and CD4 count increases) of three different ARV regimens for triple class-experienced HIV-1 infected ...
Among treatment-naive people with HIV (PWH), dolutegravir/lamivudine demonstrates effectiveness comparable with those of the commonly prescribed three-drug regimens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results